相关实验视频
Updated: Sep 9, 2025
06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
22.1K
针对肌肉的LNP疫苗能够对疹病毒产生强烈的免疫反应
Honglei Zhang1, Jingxuan Ma1, Lijie Jin1
1Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing, 100176, China.
Drug delivery and translational research
|September 1, 2025
概括
研究人员为信使RNA (mRNA) 输送系统开发了新的可离子化脂质. 这些新的脂质纳米颗粒 (LNP) 显示出潜在的mRNA疫苗的改善组织向性和增强免疫性.
科学领域:
- 生物技术
- 疫苗学
- 药物输送系统
背景情况:
- 传递 RNA (mRNA) 疗法具有广泛的医疗潜力,而脂质纳米颗粒 (LNP) 是先进的输送工具.
- 脱离目标组织的输送对LNP来说是一个挑战,需要开发多种可离子化脂质以优化输送.
- 目前的LNP技术在精确的组织向和免疫性方面存在局限性,影响治疗效果.
研究的目的:
- 设计和合成新的可离子化脂质以增强mRNA输送.
- 评估新的LNP配方的物理化学特性,细胞毒性和转染效率.
- 评估LNP提供的mRNA疫苗的体内性能,免疫性和安全性.
主要方法:
- 合成21种新的可离子化脂质并制成脂质纳米颗粒 (LNP).
- 在体外转染测试以确定高效的LNP.
- 在小鼠体内使用编码火 luciferase (Fluc) 和疹病毒 (VZV) 糖蛋白E (gE) 的mRNA研究.
主要成果:
- 三种新型LNP (YK-305,YK-310,YK-319) 显示出高的体外传染效率.
- 在小鼠的肌肉内注射mRNA- LNP显示高肌肉转移和减少肝脏基因表达.
- VZV gE- mRNA LNP诱导了强大的免疫反应,在选择性和免疫性方面超过了SM-102,并证明了安全性.
结论:
- 可以优化新型的可离子化脂质以提供向的mRNA,从而提高疫苗的选择性和免疫性.
- 这些发现支持基于LNP的mRNA疫苗的发展,其提高了组织向性和有效性.
- 开发的可离子化脂质为下一代mRNA疗法和疫苗提供了基础.
更多相关视频
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
15.9K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.6K
相关概念视频
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
01:51Vaccinations
45.3K
Overview
45.3K
01:29Immune Response Against Viral Pathogens
917
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
917
01:23Immunological Memory
4.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
4.8K